Management of cardiac implantable electronic device infections: The challenges of understanding the scope of the problem and its associated mortality

Expert Review of Cardiovascular Therapy

Volumn 11, Issue 5, 2013, Pages 607-616

  Tarakji, Khaldoun G ^a   Wilkoff, Bruce L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

cardiac implantable electronic device; complication; defibrillator; endocarditis; extraction; infection; pacemaker

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTIFICIAL HEART PACEMAKER; BACTERIAL ENDOCARDITIS; CARDIAC IMAGING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DEVICE INFECTION; DIABETES MELLITUS; DISEASE ASSOCIATION; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PROPIONIBACTERIUM ACNES; QUALITY OF LIFE; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SURVIVAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANTI-BACTERIAL AGENTS; CARDIAC SURGICAL PROCEDURES; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; HUMANS; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS;

EID: 84876903506     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.12.190     Document Type: Review

References (52)

1. Hayes DL, Furman S. Cardiac pacing: how it started, where we are, where we are going. Pacing Clin. Electrophysiol. 27(5), 693-704 (2004).
2. Wilkoff BL, Auricchio A, Brugada J et al.; Heart Rhythm Society; European Heart Rhythm Association; American College of Cardiology; American Heart Association; European Society of Cardiology; Heart Failure Association of ESC; Heart Failure Society of America. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm 5(6), 907-925 (2008).
3. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 295(7), 809-818 (2006).
4. Baddour LM, Epstein AE, Erickson CC et al.; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care; American Heart Association. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 121(3), 458-477 (2010).
5. Epstein AE, DiMarco JP, Ellenbogen KA et al.; American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117(21), e350-e408 (2008).
6. Greenspon AJ, Patel JD, Lau E et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J. Am. Coll. Cardiol. 58(10), 1001-1006 (2011).
7. Mond HG, Irwin M, Morillo C, Ector H. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2001. Pacing Clin. Electrophysiol. 27(7), 955-964 (2004).
8. Uslan DZ, Tleyjeh IM, Baddour LM et al. Temporal trends in permanent pacemaker implantation: a population-based study. Am. Heart J. 155(5), 896-903 (2008).
9. Tarakji KG, Chan EJ, Cantillon DJ et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm 7(8), 1043-1047 (2010).
10. Baddour LM, Bettmann MA, Bolger AF et al.; AHA. Nonvalvular cardiovascular device-related infections. Circulation 108(16), 2015-2031 (2003).
11. Mela T, McGovern BA, Garan H et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. Am. J. Cardiol. 88(7), 750-753 (2001).
12. Lai KK, Fontecchio SA. Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. Clin. Infect. Dis. 27(2), 265-269 (1998).
13. Smith PN, Vidaillet HJ, Hayes JJ et al. Infections with nonthoracotomy implantable cardioverter defibrillators: can these be prevented? Endotak Lead Clinical Investigators. Pacing Clin. Electrophysiol. 21(1 Pt 1), 42-55 (1998).
14. Frame R, Brodman RF, Furman S, Andrews CA, Gross JN. Surgical removal of infected transvenous pacemaker leads. Pacing Clin. Electrophysiol. 16(12), 2343-2348 (1993).
15. Hill PE. Complications of permanent transvenous cardiac pacing: a 14-year review of all transvenous pacemakers inserted at one community hospital. Pacing Clin. Electrophysiol. 10(3 Pt 1), 564-570 (1987).
16. Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RG. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br. Heart J. 73(6), 571-575 (1995).
17. Wilkoff BL. How to treat and identify device infections. Heart Rhythm 4(11), 1467-1470 (2007).
18. Klug D, Balde M, Pavin D et al.; PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 116(12), 1349-1355 (2007).
19. Uslan DZ, Sohail MR, St Sauver JL et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch. Intern. Med. 167(7), 669-675 (2007).
20. Poole JE, Gleva MJ, Mela T et al.; REPLACE Registry Investigators. Complication rates associated with pacemaker or implantable cardioverter- defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation 122(16), 1553-1561 (2010).
21. Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J. Am. Coll. Cardiol. 46(8), 1536-1540 (2005).
22. Cabell CH, Heidenreich PA, Chu VH et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am. Heart J. 147(4), 582-586 (2004).
23. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J. Am. Coll. Cardiol. 48(3), 590-591 (2006).
24. Uslan DZ, Gleva MJ, Warren DK et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry. Pacing Clin. Electrophysiol. 35(1), 81-87 (2012).
25. Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ. Arrhythm. Electrophysiol. 2(2), 129-134 (2009).
26. Sohail MR, Uslan DZ, Khan AH et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J. Am. Coll. Cardiol. 49(18), 1851-1859 (2007).
27. Bongiorni MG, Tascini C, Tagliaferri E et al. Microbiology of cardiac implantable electronic device infections. Europace 14(9), 1334-1339 (2012).
28. Bloom H, Heeke B, Leon A et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin. Electrophysiol. 29(2), 142-145 (2006).
29. Lekkerkerker JC, van Nieuwkoop C, Trines SA et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 95(9), 715-720 (2009).
30. Sohail MR, Uslan DZ, Khan AH et al. Risk factor analysis of permanent pacemaker infection. Clin. Infect. Dis. 45(2), 166-173 (2007).
31. Borleffs CJ, Thijssen J, de Bie MK et al. Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin. Electrophysiol. 33(8), 1013-1019 (2010).
32. Nery PB, Fernandes R, Nair GM et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J. Cardiovasc. Electrophysiol. 21(7), 786-790 (2010).
33. Trappe HJ, Pfitzner P, Klein H, Wenzlaff P. Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years. Br. Heart J. 73(1), 20-24 (1995).
34. Chamis AL, Peterson GE, Cabell CH et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter- defibrillators. Circulation 104(9), 1029-1033 (2001).
35. Uslan DZ, Sohail MR, Friedman PA et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with Gram-negative bacteremia. Clin. Infect. Dis. 43(6), 731-736 (2006).
36. Le KY, Sohail MR, Friedman PA et al.; Mayo Cardiovascular Infections Study Group. Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin. Electrophysiol. 34(4), 450-459 (2011).
37. Golzio PG, Fanelli AL, Vinci M et al. Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects. Europace 15(1), 89-100 (2013).
38. Dalal A, Asirvatham SJ, Chandrasekaran K, Seward JB, Tajik AJ. Intracardiac echocardiography in the detection of pacemaker lead endocarditis. J. Am. Soc. Echocardiogr. 15(9), 1027-1028 (2002).
39. Bongiorni MG, Di Cori A, Soldati E et al. Intracardiac echocardiography in patients with pacing and defibrillating leads: a feasibility study. Echocardiography 25(6), 632-638 (2008).
40. Erba PA, Conti U, Lazzeri E et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J. Nucl. Med. 53(8), 1235-1243 (2012).
41. Sarrazin JF, Philippon F, Tessier M et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J. Am. Coll. Cardiol. 59(18), 1616-1625 (2012).
42. Athan E, Chu VH, Tattevin P et al.; ICE-PCS Investigators. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA 307(16), 1727-1735 (2012).
43. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann. Intern. Med. 133(8), 604-608 (2000).
44. Cacoub P, Leprince P, Nataf P et al. Pacemaker infective endocarditis. Am. J. Cardiol. 82(4), 480-484 (1998).
45. Grammes JA, Schulze CM, Al-Bataineh M et al. Percutaneous pacemaker and implantable cardioverter-defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram. J. Am. Coll. Cardiol. 55(9), 886-894 (2010).
46. Pérez Baztarrica G, Gariglio L, Salvaggio F et al. Transvenous extraction of pacemaker leads in infective endocarditis with vegetations =20 mm: our experience. Clin. Cardiol. 35(4), 244-249 (2012).
47. Ferguson TB Jr, Ferguson CL, Crites K, Crimmins-Reda P. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J. Thorac. Cardiovasc. Surg. 111(4), 742-751; discussion 751 (1996).
48. Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch. Intern. Med. 171(20), 1821-1828 (2011).
49. Klug D, Lacroix D, Savoye C et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 95(8), 2098-2107 (1997).
50. Le KY, Sohail MR, Friedman PA et al.; Mayo Cardiovascular Infections Study Group. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm 8(11), 1678-1685 (2011).
51. de Bie MK, van Rees JB, Thijssen J et al. Cardiac device infections are associated with a significant mortality risk. Heart Rhythm 9(4), 494-498 (2012).
52. Deharo JC, Quatre A, Mancini J et al. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart 98(9), 724-731 (2012).